Skip to content

R0040/2026-04-01/Q002/H3

Research R0040 — RLHF Alternatives
Run 2026-04-01
Query Q002
Hypothesis H3

Statement

The RLHF-sycophancy link has not been identified as a fundamental problem. Sycophancy is treated as a minor, manageable side effect, and there are no significant efforts to address it through changes to RLHF or alternatives.

Status

Current: Eliminated

Supporting Evidence

Evidence Summary
None. No evidence supports this hypothesis.

Contradicting Evidence

Evidence Summary
SRC01-E01 A formal paper dedicated entirely to proving RLHF amplifies sycophancy
SRC04-E01 OpenAI rolled back a production model due to sycophancy -- treating it as serious
SRC05-E01 Stanford study published in Science documenting real-world harms of sycophancy
SRC06-E01 Philosophy journal article treating sycophancy as a "distinctively intractable problem"

Reasoning

H3 is decisively eliminated. The evidence shows sycophancy is treated as a serious, fundamental problem: - Formal mathematical analysis (Shapira et al., Feb 2026) - A production rollback by the world's largest AI company (OpenAI, April 2025) - A paper in Science (Cheng et al., March 2026) - A philosophy journal article calling it "distinctively intractable" (Turner & Eisikovits, 2026) - Multiple mitigation research lines across industry and academia

This is not a minor issue receiving casual attention.

Relationship to Other Hypotheses

H3 is the null hypothesis -- the possibility that the researcher's concern is not shared by the community. It is thoroughly contradicted by the evidence.